Registry finds 3 drugs most favored PEP regimen.
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002487:Centers for Disease Control and Prevention, U.S.; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D017408:Guidelines as Topic; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006282:Health Personnel; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D019259:Lamivudine / Q000008:administration & dosage*; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure; D012042:Registries; D014481:United States; D015215:Zidovudine / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine